Advantages and disadvantages of the ketogenic diet: a review article
February Feb 27: In one of the more closely watched decisions of the first quarter of 2024, the FDA rejected Minerva Neurosciences roluperidone, which had been proposed to treat the negative symptoms of schizophrenia
Practical Implementation for Real Life The honest comparison reveals that neither is superior in isolation
What to monitor if on retatrutide and experiencing dysesthesia: When it started (which dose, which week) Severity progression (stable, worsening, improving) Impact on daily activities Response to dose reduction Report persistent or worsening dysesthesia to your doctor
Komajda M, McMurray JJ, Beck-Nielsen H, Gomis R, Hanefeld M, Pocock SJ, Curtis PS, Jones NP, Home PD